Eventide Healthcare Life Fund Investor Sentiment

ETCHX Fund  USD 35.06  0.69  1.93%   
Slightly above 62% of Eventide Healthcare's investor base is looking to short. The analysis of overall sentiment of trading Eventide Healthcare Life mutual fund suggests that many investors are alarmed at this time. Eventide Healthcare's investing sentiment can be driven by a variety of factors including economic data, Eventide Healthcare's earnings reports, geopolitical events, and overall market trends.
  
Eventide Healthcare stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Eventide earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
There is far too much social signal, news, headlines, and media speculation about Eventide Healthcare that are available to investors today. This information is accessible both publicly - through Eventide Healthcare's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Eventide-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Eventide Healthcare news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Eventide Healthcare relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Eventide Healthcare's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Eventide Healthcare alpha.
few days ago at news.google.com         
Opinion Stablecoins, Money-Market Funds and the SL Crisis - The Wall Street Journal
Google News at Macroaxis
over a year ago at news.google.com         
EVENTIDE HEALTHCARE LIFE SCIENCES FUND CELEBRATES ... - Valdosta Daily Times
Google News at Macroaxis
a day ago at news.google.com         
Market Trends Is Collegium Pharmaceutical Inc a good stock for dollar cost averaging - 2025 Sector R...
Google News at Macroaxis
few days ago at finance.yahoo.com         
Q2 Earnings Roundup Corcept And The Rest Of The Branded Pharmaceuticals Segment
Yahoo News
over a week ago at thelincolnianonline.com         
Fortis Capital Advisors LLC Takes 408,000 Position in Collegium Pharmaceutical, Inc. COLL
news
over two weeks ago at news.google.com         
Collegium Pharmaceutical Inc. stock chart pattern explained - 2025 Geopolitical Influence Consistent...
Google News at Macroaxis
over two weeks ago at finance.yahoo.com         
Collegium Pharmaceutical, Inc. to Present 9 Pain Studies at PAINWeek 2025
Yahoo News
over two weeks ago at simplywall.st         
Is Collegiums Real-World Pain Data Shaping Its Competitive Edge in Chronic Care?
Simply Wall St News at Macroaxis
over two weeks ago at finance.yahoo.com         
Collegium Pharmaceutical, Inc. Highlights Real-World Evidence at PAINWeek 2025
Yahoo News
over three weeks ago at thelincolnianonline.com         
Campbell CO Investment Adviser LLC Takes Position in Collegium Pharmaceutical, Inc. COLL
news
over three weeks ago at thelincolnianonline.com         
Insider Selling Collegium Pharmaceutical Director Sells 5,405 Shares of Stock
news
over three weeks ago at simplywall.st         
Collegium Pharmaceutical Updated Guidance and Buybacks Spark Fresh Valuation Focus After Q2 Results
Simply Wall St News at Macroaxis
over a year ago at seekingalpha.com         
Tectonic, AVROBIO complete merger, announce 130.7M private placement
seekingalpha News
over a year ago at news.google.com         
Gabelli Funds LLC Invests 467000 in AVROBIO, Inc. - Defense World
Google News at Macroaxis
over a year ago at news.google.com         
AVROBIO, Inc. Short Interest Up 11.3 percent in May - MarketBeat
Google News at Macroaxis
over a year ago at investing.com         
Avrobio executive buys shares worth over 970k
Investing News at Macroaxis
over a year ago at investorplace.com         
AVRO Stock Earnings Avrobio Beats EPS for Q1 2024
sbwire news
over a year ago at news.google.com         
AVROBIO Options Chain Prices 2024 - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
AVROBIO Posts Quarterly Earnings Results - MarketBeat
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
AVROBIO, Inc. Short Interest Update
news
over a year ago at benzinga.com         
SHAREHOLDER UPDATE Halper Sadeh LLC Investigates AXNX, KAMN, JNPR, AVRO
benzinga news
over a year ago at news.google.com         
AVROBIO INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick Foti, LLC Investigates...
Google News at Macroaxis
2 days ago at thelincolnianonline.com         
Supernus Pharmaceuticals SVP Sells 229,350.00 in Stock
news
few days ago at finance.yahoo.com         
3 Reasons to Avoid SUPN and 1 Stock to Buy Instead
Yahoo News
over a week ago at www.macroaxis.com         
Disposition of 5000 shares by Frank Mottola of Supernus Pharmaceuticals at .4 subject to Rule 16b-3
Macroaxis News
over a week ago at simplywall.st         
Acquisition by Jack Khattar of 19320 shares of Supernus Pharmaceuticals subject to Rule 16b-3
Simply Wall St News at Macroaxis
over a week ago at finance.yahoo.com         
Can Mixed Fundamentals Have A Negative Impact on Supernus Pharmaceuticals, Inc. Current Share Price ...
Yahoo News
over two weeks ago at thelincolnianonline.com         
Supernus Pharmaceuticals Reaches New 52-Week High Heres Why
news
over two weeks ago at insidermonkey.com         
Sage Therapeutics, Inc. Bought by Supernus to Boost Neuropsychiatric Portfolio
insidermonkey News
over two weeks ago at thelincolnianonline.com         
Retirement Planning Co of New England Inc. Cuts Position in Supernus Pharmaceuticals, Inc. SUPN
news
over three weeks ago at globenewswire.com         
Disposition of 3588 shares by Newhall Charles W Iii of Supernus Pharmaceuticals at 45.01 subject to ...
Macroaxis News: globenewswire.com
over three weeks ago at thelincolnianonline.com         
BI Asset Management Fondsmaeglerselskab A S Takes Position in Supernus Pharmaceuticals, Inc. SUPN
news
2 days ago at news.google.com         
AQR Capital Management LLC Sells 34,410 Shares of Veracyte, Inc. VCYT - MarketBeat
Google News at Macroaxis
six days ago at thelincolnianonline.com         
Analysts Set Veracyte, Inc. PT at 40.90
news
over a week ago at finance.yahoo.com         
Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American T...
Yahoo News
over two weeks ago at news.google.com         
What are the future prospects of Veracyte Inc. - Dollar Strength Low Risk High Reward Ideas -
Google News at Macroaxis
over two weeks ago at simplywall.st         
Will New Clinical Evidence and Trial Progress Expand Veracytes Role in Precision Oncology?
Simply Wall St News at Macroaxis
over two weeks ago at zacks.com         
Heres How Much a 1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today
zacks News
over three weeks ago at finance.yahoo.com         
Veracyte Announces New Study Published in Cell Shows that Decipher Prostate Test Predicts Chemothera...
Yahoo News
over three weeks ago at zacks.com         
Tempus Key Acquisitions Strengthen Its AI Healthcare Leadership
zacks News
over three weeks ago at thelincolnianonline.com         
76,342 Shares in Veracyte, Inc. VCYT Acquired by Campbell CO Investment Adviser LLC
news
over three weeks ago at zacks.com         
Heres Why Veracyte is a Strong Momentum Stock
zacks News
a day ago at benzinga.com         
Beyond The Numbers 28 Analysts Discuss Alnylam Pharmaceuticals Stock
benzinga news
3 days ago at thelincolnianonline.com         
Alnylam Pharmaceuticals, Inc. Receives 421.28 Average Target Price from Brokerages
news
few days ago at news.google.com         
Smart Money Whats the beta of Alnylam Pharmaceuticals Inc stock - Gap Up Verified Entry Point Detect...
Google News at Macroaxis
over a week ago at thelincolnianonline.com         
Insider Selling Alnylam Pharmaceuticals Director Sells 18,000 Shares of Stock
news
over a week ago at thelincolnianonline.com         
Top Pharmaceutical Stocks To Follow Today September 10th
news
over a week ago at finance.yahoo.com         
Alnylam Surges 6.0 percent Is This an Indication of Further Gains?
Yahoo News
over a week ago at simplywall.st         
Alnylam Pharmaceuticals Assessing Valuation After HELIOS-B Study Reveals Long-Term AMVUTTRA Benefits
Simply Wall St News at Macroaxis
over a week ago at thefly.com         
Alnylam price target raised by 20 at BMO Capital, heres why ALNYRHHBY
news
over a week ago at seekingalpha.com         
Alnylam announces proposed offering of 500M convertible senior notes
seekingalpha News
over a week ago at simplywall.st         
How Investors May Respond To Alnylam Pharmaceuticals Positive Long-Term HELIOS-B Results for AMVUTTR...
Simply Wall St News at Macroaxis
over three months ago at businesswire.com         
bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital
businesswire News
over three months ago at finance.yahoo.com         
bluebird bio, Inc. Nears Acquisition by Carlyle and SK Capital
Yahoo News
over three months ago at businesswire.com         
Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
businesswire News
over three months ago at gurufocus.com         
Disposition of 155 shares by Paulson Richard A. of Bluebird Bio at 3.0 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over three months ago at gurufocus.com         
bluebird bio Reminds Stockholders to Act Now to Tender Shares for Acquisition by Carlyle and SK ...
Gurufocus Stories at Macroaxis
over three months ago at finance.yahoo.com         
Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions
Yahoo News
over three months ago at gurufocus.com         
Bluebird Bio Amends Deal with SK Capital for Shareholder Options BLUE Stock News
Gurufocus Stories at Macroaxis
over three months ago at finance.yahoo.com         
Bluebird Q1 Earnings Snapshot
Yahoo News
over three months ago at gurufocus.com         
Important Information for bluebird bio Stockholders to Tender Shares for Acquisition by Carlyle ...
Gurufocus Stories at Macroaxis
over three months ago at finance.yahoo.com         
Bluebird pleads for deal support Unity, Mersana lay off staff
Yahoo News
2 days ago at news.google.com         
Buyout Rumor Is Voyager Therapeutics Inc. subject to activist investor interest - 2025 Market Outloo...
Google News at Macroaxis
few days ago at finance.yahoo.com         
Voyager Therapeutics Alzheimers Portfolio And ALPL NeuroShuttle Underscore Platform Momentum Analyst
Yahoo News
over two weeks ago at news.google.com         
Can Voyager Therapeutics Inc. continue delivering strong returns - Inflation Watch Step-by-Step Trad...
Google News at Macroaxis
over two weeks ago at news.google.com         
Published on 2025-09-01 140537 - Newser
Google News at Macroaxis
over two weeks ago at news.google.com         
Volume spikes in Voyager Therapeutics Inc. stock what they mean - 2025 Price Momentum Target Return ...
Google News at Macroaxis
over three weeks ago at news.google.com         
Using fundamentals and technicals on Voyager Therapeutics Inc. - Earnings Recap Report Weekly High C...
Google News at Macroaxis
over a month ago at news.google.com         
Analysts Spot Bullish Divergence in Voyager Therapeutics Inc. - Quarterly Profit Report Entry Point ...
Google News at Macroaxis
over a month ago at news.google.com         
Voyager Therapeutics Strategic Positioning and Promising Pipeline Drive Buy Rating - TipRanks
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
Voyager Therapeutics Price Target Lowered to 8.00 at Wedbush
news
over a month ago at zacks.com         
Voyager Therapeutics Reports Q2 Loss, Lags Revenue Estimates
zacks News
over a week ago at finance.yahoo.com         
Galapagos NV CAR-T Therapy Hits 97 percent Response Rate in Lymphoma Trial
Yahoo News
over a month ago at thelincolnianonline.com         
Galapagos Sell Rating Reaffirmed at Deutsche Bank Aktiengesellschaft
news
over a month ago at thelincolnianonline.com         
Galapagos Lowered to Sell Rating by Deutsche Bank Aktiengesellschaft
news
over a month ago at benzinga.com         
Why Alphabet Shares Are Trading Higher Here Are 20 Stocks Moving Premarket
benzinga news
over two months ago at gurufocus.com         
Galapagos Appoints New CFO as Aaron Cox Steps In GLPG Stock News
Gurufocus Stories at Macroaxis
over three months ago at insidermonkey.com         
Galapagos NV CAR-T Therapy Hits 97 percent Response Rate in Lymphoma Trial
insidermonkey News
over three months ago at seekingalpha.com         
Galapagos stock gains after naming CEO
seekingalpha News
over three months ago at gurufocus.com         
Q1 2025 Galapagos NV Earnings Call Transcript
Gurufocus Stories at Macroaxis
over three months ago at gurufocus.com         
Galapagos Announces Key Leadership Changes Amid Strategic Separation GLPG Stock News
Gurufocus Stories at Macroaxis
over six months ago at gurufocus.com         
Stonepine Capital Management, LLC Acquires Significant Stake in Edesa Biotech Inc
Gurufocus Stories at Macroaxis
a minute ago at thelincolnianonline.com         
AbbVie Inc. Shares Sold by Janney Montgomery Scott LLC
news
a day ago at thelincolnianonline.com         
Western Pacific Wealth Management LP Decreases Holdings in AbbVie Inc. ABBV
news
3 days ago at thelincolnianonline.com         
Radnor Capital Management LLC Buys 629 Shares of AbbVie Inc. ABBV
news
few days ago at thelincolnianonline.com         
Westmount Partners LLC Reduces Holdings in AbbVie Inc. ABBV
news
few days ago at cnbc.com         
Fed rate cuts will make dividend stocks more appealing for income investors. Here are a few standout...
cnbc News
few days ago at simplywall.st         
How the Bretisilocin Acquisition Could Shift AbbVies 2025 Valuation Debate
Simply Wall St News at Macroaxis
few days ago at thelincolnianonline.com         
TruWealth Advisors LLC Has 26.46 Million Stock Holdings in AbbVie Inc. ABBV
news
few days ago at thelincolnianonline.com         
Wealth Alliance Advisory Group LLC Grows Stock Holdings in AbbVie Inc. ABBV
news
six days ago at thelincolnianonline.com         
Sage Capital Advisors llc Acquires 247 Shares of AbbVie Inc. ABBV
news
over a week ago at finance.yahoo.com         
Meet the Vanguard ETF That Yields More Than Twice the SP 500 Average and Has Minimal Fees
Yahoo News
a minute ago at gurufocus.com         
Sarepta Jefferies Adjusts Price Target Amid Elevidys Sales Update SRPT Stock News
Gurufocus Stories at Macroaxis
3 days ago at www.macroaxis.com         
Insider Trading
Macroaxis News
few days ago at benzinga.com         
Expert Outlook Sarepta Therapeutics Through The Eyes Of 43 Analysts
benzinga news
few days ago at simplywall.st         
Insider Trading
Simply Wall St News at Macroaxis
over a week ago at independent.co.uk         
Mom unable to get treatment for one of two boys with rare genetic disorder gets life-changing update...
news
over a week ago at finance.yahoo.com         
Avidity touts disease reversal potential of DMD therapy
Yahoo News
over a week ago at independent.co.uk         
Two brothers have the same genetic disorder. Their insurance only covered life-altering treatment fo...
news
over a week ago at www.macroaxis.com         
Insider Trading
Macroaxis News
over two weeks ago at finance.yahoo.com         
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 202...
Yahoo News
over two weeks ago at finance.yahoo.com         
Sarepta Therapeutics Fell Despite Reporting Good Results
Yahoo News
over a year ago at smh.com.au         
Billionaire pleads guilty in insider trading case with a link to an Australian giant
news
over a year ago at finance.yahoo.com         
Billionaire Joe Lewis Pleads Guilty in Insider Trading Case
Yahoo News
over a year ago at thelincolnianonline.com         
Mirati Therapeutics Now Covered by Analysts at StockNews.com
news
over a year ago at aol.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
news
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over a year ago at seekingalpha.com         
Mirati Therapeutics stock ticks higher amid Nasdaq delisting for sale to Bristol-Myers
seekingalpha News
over a year ago at thelincolnianonline.com         
Brokerages Set Mirati Therapeutics, Inc. PT at 60.00
news
a day ago at news.google.com         
Aug Closing Will 908 Devices Inc. benefit from rising consumer demand - Inflation Watch Verified Swi...
Google News at Macroaxis
over a week ago at thelincolnianonline.com         
908 Devices Inc. Given Consensus Recommendation of Buy by Brokerages
news
over a week ago at www.macroaxis.com         
Disposition of 2058 shares by Hunt Anthony of 908 Devices subject to Rule 16b-3
Macroaxis News
over two weeks ago at thelincolnianonline.com         
908 Devices Upgraded by Wall Street Zen to Hold Rating
news
over two weeks ago at news.google.com         
Is 908 Devices Inc. stock ready for a breakout - CEO Change AI Forecasted EntryExit Points - Newser
Google News at Macroaxis
over three weeks ago at news.google.com         
Can technical indicators confirm 908 Devices Inc.s reversal - Market Activity Report High Accuracy B...
Google News at Macroaxis
over three weeks ago at news.google.com         
Is 908 Devices Inc. stock bottoming out - Trade Analysis Summary Short-Term High Return Strategies -...
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Acquisition by Vann Brandi C of 20409 shares of 908 Devices at 5.14 subject to Rule 16b-3
Macroaxis News
over a month ago at news.google.com         
908 Devices Inc. shares rise 8.11 percent intraday after PolyPid reported positive Phase 3 SHIELD II...
Google News at Macroaxis
over a month ago at fool.com         
908 Devices Q2 Revenue Jumps 14
fool News
a minute ago at finance.yahoo.com         
Neurocrines Phase II schizophrenia trial fails to meet primary endpoint
Yahoo News
few days ago at finance.yahoo.com         
Neurocrine Biosciences to Present New Data from Phase 2 Study of Osavampator in Adults with Major De...
Yahoo News
six days ago at news.google.com         
Vident Advisory LLC Invests 202,000 in Neurocrine Biosciences, Inc. NBIX - MarketBeat
Google News at Macroaxis
over a week ago at thelincolnianonline.com         
Peloton Wealth Strategists Boosts Stock Holdings in Neurocrine Biosciences, Inc. NBIX
news
over a week ago at thelincolnianonline.com         
Advisors Asset Management Inc. Acquires 366 Shares of Neurocrine Biosciences, Inc. NBIX
news
over two weeks ago at thelincolnianonline.com         
Baird Financial Group Inc. Boosts Holdings in Neurocrine Biosciences, Inc. NBIX
news
over two weeks ago at finance.yahoo.com         
Neurocrine Biosciences, Inc. Beats Estimates on Neurology Drug Demand, Expands Payer Access
Yahoo News
over two weeks ago at news.google.com         
Custom watchlist performance reports with Neurocrine Biosciences Inc. - Market Growth Review Free Fa...
Google News at Macroaxis
over two weeks ago at news.google.com         
Will Neurocrine Biosciences Inc. price bounce be sustainable - Weekly Market Report Community Consen...
Google News at Macroaxis
over three weeks ago at thelincolnianonline.com         
Ieq Capital LLC Sells 20,887 Shares of Neurocrine Biosciences, Inc. NBIX
news
2 days ago at news.google.com         
Nurix Therapeutics Shares Up 6.5 percent - Time to Buy - MarketBeat
Google News at Macroaxis
few days ago at news.google.com         
Nurix Therapeutics Trading Down 6.5 percent - Should You Sell - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Parkman Healthcare Partners LLC Sells 181,752 Shares of Nurix Therapeutics, Inc. NRIX - MarketBeat
Google News at Macroaxis
over two weeks ago at news.google.com         
What to do if youre stuck in Nurix Therapeutics Inc. - July 2025 Momentum Accurate Trade Setup Notif...
Google News at Macroaxis
over two weeks ago at news.google.com         
Applying big data sentiment scoring on Nurix Therapeutics Inc. - Wall Street Watch Risk Adjusted Buy...
Google News at Macroaxis
over two weeks ago at news.google.com         
Nurix Therapeutics, Inc. NRIX Shares Acquired by Russell Investments Group Ltd. - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
Nurix Therapeutics, Inc. NRIX Shares Bought by T. Rowe Price Investment Management Inc. - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
What institutional flow reveals about Nurix Therapeutics Inc. - Trade Volume Summary Weekly High Mom...
Google News at Macroaxis
over a month ago at news.google.com         
Deutsche Bank AG Has 4.52 Million Position in Nurix Therapeutics, Inc. NRIX - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Nurix Therapeutics Trading Up 7.7 percent - Should You Buy - MarketBeat
Google News at Macroaxis
over a year ago at www.macroaxis.com         
Disposition of 8500 shares by Jonas Jeffrey M of Karuna Therapeutics at 128.01 subject to Rule 16b-3
Macroaxis News
over a year ago at bizjournals.com         
PureTechs newest biotech spinout represents a shift from the past
bizjournals News
over a year ago at news.google.com         
Disposition of 17350 shares by Stephen Brannan of Karuna Therapeutics at 187.26 subject to Rule 16b-...
Google News at Macroaxis
over a year ago at simplywall.st         
When Will Karuna Therapeutics, Inc. Turn A Profit?
Simply Wall St News at Macroaxis
over a year ago at news.google.com         
Karuna Therapeutics, Inc. Receives Consensus Recommendation of Hold from Analysts - Defense World
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Bronte Amalthea Fund Incurred Loss in Karuna Therapeutics Short Position
Yahoo News
over a year ago at www.macroaxis.com         
Acquisition by Steven Paul of 47378 shares of Karuna Therapeutics at 315.18 subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Disposition of 27510 shares by Steven Paul of Karuna Therapeutics at 7.27 subject to Rule 16b-3
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Algert Global LLC Has 3.12 Million Stock Holdings in Karuna Therapeutics, Inc.
news
over a year ago at gurufocus.com         
Decoding Karuna Therapeutics Inc A Strategic SWOT Insight
Gurufocus Stories at Macroaxis
3 days ago at news.google.com         
Acadian Asset Management LLC Increases Stock Holdings in Sutro Biopharma, Inc. STRO - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
What is the dividend yield of Sutro Biopharma Inc. - Weekly Profit Recap Daily Entry Point Trade Ale...
Google News at Macroaxis
over two weeks ago at news.google.com         
Real time breakdown of Sutro Biopharma Inc. stock performance - Quarterly Portfolio Summary Daily En...
Google News at Macroaxis
over two weeks ago at news.google.com         
Using data models to predict Sutro Biopharma Inc. stock movement - Trade Exit Summary AI Powered Buy...
Google News at Macroaxis
over three weeks ago at news.google.com         
Sutro Biopharma Inc. stock chart pattern explained - Analyst Downgrade Weekly High Return Stock Fore...
Google News at Macroaxis
over a month ago at news.google.com         
How Sutro Biopharma Inc. stock performs during market volatility - Quarterly Market Review Free Expe...
Google News at Macroaxis
over a month ago at simplywall.st         
Sutro Biopharma Second Quarter 2025 Earnings Beats Expectations
Simply Wall St News at Macroaxis
over a month ago at finance.yahoo.com         
Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights
Yahoo News
over a month ago at news.google.com         
How Sutro Biopharma Inc. stock reacts to Fed policy changes - Unrivaled growth potential - jammulink...
Google News at Macroaxis
over a month ago at finance.yahoo.com         
Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for An...
Yahoo News
2 days ago at thelincolnianonline.com         
Xencor Upgraded by Barclays to Strong Sell Rating
news
few days ago at thefly.com         
Xencor assumed with an Underweight at Barclays XNCR
news
over a week ago at news.google.com         
155,580 Shares in Xencor, Inc. XNCR Bought by Cubist Systematic Strategies LLC - MarketBeat
Google News at Macroaxis
over a week ago at finance.yahoo.com         
RBC Cuts Xencor Price Target but Keeps Outperform Rating
Yahoo News
over two weeks ago at thelincolnianonline.com         
Wedbush Reaffirms Outperform Rating for Xencor
news
over two weeks ago at seekingalpha.com         
Erasca, Candle, Xencor drop as BofA downgrades
seekingalpha News
over two weeks ago at thelincolnianonline.com         
Nantahala Capital Management LLC Invests 4.86 Million in Xencor, Inc. XNCR
news
over two weeks ago at news.google.com         
Real time scanner hits for Xencor Inc. explained - Weekly Market Summary Daily Growth Stock Tips - N...
Google News at Macroaxis
over three weeks ago at news.google.com         
Using data models to predict Xencor Inc. stock movement - Day Trade Daily Profit Maximizing Tips - N...
Google News at Macroaxis
over three weeks ago at thefly.com         
Xencor price target lowered by 17 at RBC Capital, heres why XNCR
news
over three months ago at news.google.com         
Allakos stock hits 52-week low at 0.3 amid market challenges - MSN
Google News at Macroaxis
over three months ago at thelincolnianonline.com         
Allakos Inc. Shares Purchased by Bridgeway Capital Management LLC
news
over three months ago at www.macroaxis.com         
Acquisition by Paterson Craig A. of 157428 shares of Allakos subject to Rule 16b-3
Macroaxis News
over three months ago at seekingalpha.com         
Allakos stock surges on reverse merger deal
seekingalpha News
over three months ago at businesswire.com         
ALLK Stock Alert Halper Sadeh LLC Is Investigating Whether the Sale of Allakos Inc. Is Fair to Share...
businesswire News
over three months ago at gurufocus.com         
SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates COOP, RDFN, ALLK on Behalf of Shareholders
Gurufocus Stories at Macroaxis
over three months ago at news.google.com         
Allakos stock plunges to 52-week low of 0.23 amid market challenges - Investing.com UK
Google News at Macroaxis
over six months ago at news.google.com         
Allakos Reports Q4 2024 Results Amid Strategic Shift - TipRanks
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Disposition of 14161 shares by Radford Harlan Baird of Allakos at 0.26 subject to Rule 16b-3
Macroaxis News
over six months ago at gurufocus.com         
Kuehn Law Encourages Investors of Allakos Inc. to Contact Law Firm
Gurufocus Stories at Macroaxis
2 days ago at benzinga.com         
12 Analysts Have This To Say About argenx
benzinga news
over a week ago at finance.yahoo.com         
argenx SE Expands Autoimmune Leadership with Vyvgart Launch
Yahoo News
over a week ago at benzinga.com         
Is argenx Gaining or Losing Market Support?
benzinga news
over two weeks ago at thelincolnianonline.com         
Cinctive Capital Management LP Has 2. Million Stock Position in argenex SE ARGX
news
over two weeks ago at finance.yahoo.com         
KMDA or ARGX Which Is the Better Value Stock Right Now?
Yahoo News
over two weeks ago at thelincolnianonline.com         
BNP Paribas Financial Markets Purchases 123,127 Shares of argenex SE ARGX
news
over three weeks ago at benzinga.com         
Heres How Much 100 Invested In argenx 5 Years Ago Would Be Worth Today
benzinga news
over three weeks ago at finance.yahoo.com         
Argenx Immune Disorder Drugs Reach Could Get Much Bigger With Major Trial Win
Yahoo News
over three weeks ago at benzinga.com         
Assessing argenx Insights From 11 Financial Analysts
benzinga news
over a month ago at finance.yahoo.com         
argenx SE A Bull Case Theory
Yahoo News
3 days ago at news.google.com         
Aug Highlights Should I buy Ascendis Pharma A S Depositary Receipt stock now - 2025 Pullback Review ...
Google News at Macroaxis
few days ago at insidermonkey.com         
Morgan Stanley Remains Bullish on Ascendis Pharma
insidermonkey News
over a week ago at benzinga.com         
PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment
benzinga news
over a week ago at finance.yahoo.com         
Can drug developers help kids with dwarfism reach new heights?
Yahoo News
over two weeks ago at news.google.com         
Why Ascendis Pharma A S Depositary Receipt is moving today - July 2025 Weekly Recap Free Daily Entry...
Google News at Macroaxis
over two weeks ago at news.google.com         
What momentum shifts mean for Ascendis Pharma A S Depositary Receipt - 2025 Historical Comparison We...
Google News at Macroaxis
over three weeks ago at globenewswire.com         
Ascendis Pharma to Participate in the2025 Wells Fargo Healthcare Conference
Macroaxis News: globenewswire.com
over three weeks ago at news.google.com         
Ranking Ascendis Pharma A S Depositary Receipt among high performing stocks via tools - Market Growt...
Google News at Macroaxis
over three weeks ago at news.google.com         
Detecting price anomalies in Ascendis Pharma A S Depositary Receipt with AI - Day Trade Smart Alloca...
Google News at Macroaxis
over a month ago at benzinga.com         
If You Invested 1000 In This Stock 10 Years Ago, You Would Have This Much Today
benzinga news
few days ago at news.google.com         
Biohaven stock price target lowered to 26 at UBS on troriluzole timeline By Investing.com - Investin...
Google News at Macroaxis
over a week ago at prnewswire.com         
Biohaven Ltd. Sued for Securities Law Violations - Investors Should Contact Levi Korsinsky Before Se...
prnewswire News
over a week ago at globenewswire.com         
BHVN INVESTOR ALERT Bronstein, Gewirtz Grossman LLC Announces that Biohaven Ltd. Investors with Subs...
Macroaxis News: globenewswire.com
over a week ago at thelincolnianonline.com         
Woodline Partners LP Sells 1,473 Shares of Biohaven Ltd. BHVN
news
over a week ago at globenewswire.com         
Pomerantz Law Firm Announces the Filing of a Class Action AgainstBiohaven Ltd. and Certain Officers ...
Macroaxis News: globenewswire.com
over a week ago at globenewswire.com         
Biohaven Ltd. Investors Please contact the Portnoy Law Firm to recover your losses. September 12, 20...
Macroaxis News: globenewswire.com
over a week ago at globenewswire.com         
Shareholders that lost money on Biohaven Ltd. should contact Levi Korsinsky about pending Class Acti...
Macroaxis News: globenewswire.com
over a week ago at globenewswire.com         
BHVN INVESTOR ALERT Bronstein, Gewirtz Grossman LLC Announces that Biohaven Ltd. Investors with Subs...
Macroaxis News: globenewswire.com
over a week ago at prnewswire.com         
BHVN Deadline BHVN Investors Have Opportunity to Lead Biohaven Ltd. Securities Fraud Lawsuit
prnewswire News
over two weeks ago at globenewswire.com         
Biohaven Ltd. Investors Please contact the Portnoy Law Firm to recover your losses. September 12, 20...
Macroaxis News: globenewswire.com
a minute ago at benzinga.com         
IonQ, HE Equipment Services And ImmunityBio Are Among Top Mid Cap Gainers Last Week Are The Others I...
benzinga news
over two months ago at thelincolnianonline.com         
Growth Stocks To Follow Now July 18th
news
over two months ago at thelincolnianonline.com         
Blueprint Medicines Raised to Hold at Wall Street Zen
news
over two months ago at thelincolnianonline.com         
Blueprint Medicines Reaches New 52-Week High Heres Why
news
over two months ago at thelincolnianonline.com         
Disposition of 7500 shares by Borisy Alexis of Blueprint Medicines at 69.79 subject to Rule 16b-3
news
over two months ago at benzinga.com         
Whats Driving the Market Sentiment Around Blueprint Medicines?
benzinga news
over two months ago at thelincolnianonline.com         
Top Growth Stocks To Watch Now July 12th
news
over two months ago at thelincolnianonline.com         
Top Growth Stocks To Follow Now July 7th
news
over two months ago at benzinga.com         
Cogents Chronic Immune Disorder Drug Has Strong Potential To Become A Blockbuster Analyst
benzinga news
over two months ago at thelincolnianonline.com         
Growth Stocks To Keep An Eye On June 25th
news
a day ago at thelincolnianonline.com         
39,476 Shares in Celldex Therapeutics, Inc. CLDX Bought by Sovran Advisors LLC
news
3 days ago at thefly.com         
Celldexs barzo shows strong efficacy in CSU patients, says H.C. Wainwright CLDX
news
few days ago at news.google.com         
Travel Stocks Can Celldex Therapeutics Inc disrupt its industry - Insider Buying Fast Exit Strategy ...
Google News at Macroaxis
over a week ago at news.google.com         
20,899 Shares in Celldex Therapeutics, Inc. CLDX Bought by PDT Partners LLC - MarketBeat
Google News at Macroaxis
over a week ago at thelincolnianonline.com         
Celldex Therapeutics, Inc. Receives 46.67 Consensus Target Price from Brokerages
news
over two weeks ago at news.google.com         
Is Celldex Therapeutics Inc. stock entering bullish territory - Market Performance Recap Risk Contro...
Google News at Macroaxis
over two weeks ago at news.google.com         
Historical volatility pattern of Celldex Therapeutics Inc. visualized - Fed Meeting Capital Protecti...
Google News at Macroaxis
over two weeks ago at news.google.com         
Is now a turning point for Celldex Therapeutics Inc. - 2025 Top Gainers Verified Momentum Stock Aler...
Google News at Macroaxis
over three weeks ago at simplywall.st         
Celldex Therapeutics Is Down 8.3 percent After Barzolvolimab Misses Key Goals in EoE Trial
Simply Wall St News at Macroaxis
over three weeks ago at finance.yahoo.com         
FDA cancels adcomm on Biohaven drug Catalent lays off staff
Yahoo News
2 days ago at news.google.com         
Bull Bear What are analysts price targets for Cogent Biosciences Inc - Weekly Stock Report Community...
Google News at Macroaxis
six days ago at news.google.com         
621,678 Shares in Cogent Biosciences, Inc. COGT Purchased by Exome Asset Management LLC - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
What is Cogent Biosciences Inc. s 5 year growth outlook - 2025 Bull vs Bear High Yield Stock Recomme...
Google News at Macroaxis
over two weeks ago at news.google.com         
Cogent Biosciences Inc. stock daily chart insights - Earnings Miss AI Driven Stock Price Forecasts -...
Google News at Macroaxis
over two weeks ago at news.google.com         
Whats the recovery path for long term holders of Cogent Biosciences Inc. - July 2025 Reactions Momen...
Google News at Macroaxis
over three weeks ago at news.google.com         
Backtesting results for Cogent Biosciences Inc. trading strategies - July 2025 Breakouts Weekly Setu...
Google News at Macroaxis
over three weeks ago at news.google.com         
Is Cogent Biosciences Inc. meeting your algorithmic filter criteria - July 2025 Trends Stepwise Trad...
Google News at Macroaxis
over three weeks ago at thelincolnianonline.com         
Algert Global LLC Has 3.16 Million Stock Position in Cogent Biosciences, Inc. COGT
news
over a month ago at www.macroaxis.com         
Acquisition by Green John L. of 300000 shares of Cogent Biosciences at 4.63 subject to Rule 16b-3
Macroaxis News
over a month ago at news.google.com         
Wedbush Lowers Earnings Estimates for Cogent Biosciences - MarketBeat
Google News at Macroaxis
2 days ago at benzinga.com         
Peering Into Exact Sciencess Recent Short Interest
benzinga news
few days ago at zacks.com         
Why Exact Sciences is a Top Growth Stock for the Long-Term
zacks News
over a week ago at thelincolnianonline.com         
DLD Asset Management LP Purchases Shares of 78,500 Exact Sciences Corporation EXAS
news
over a week ago at benzinga.com         
Demystifying Exact Sciences Insights From 9 Analyst Reviews
benzinga news
over a week ago at thelincolnianonline.com         
Graham Capital Management L.P. Takes 520,000 Position in Exact Sciences Corporation EXAS
news
over two weeks ago at stockstory.org         
Why Exact Sciences Stock Is Trading Up Today
news
over two weeks ago at stockstory.org         
Exact Sciences Stock Trades Up, Here Is Why
news
over two weeks ago at finance.yahoo.com         
Jefferies Reiterates a Buy Rating on Exact Sciences Corporation
Yahoo News
over two weeks ago at finance.yahoo.com         
3 of Wall Streets Favorite Stocks Were Skeptical Of
Yahoo News
over three weeks ago at zacks.com         
Are You a Growth Investor This 1 Stock Could Be the Perfect Pick
zacks News
a day ago at news.google.com         
Kura Oncology Transitioning To Commercial Stage Why I Choose To Buy - Seeking Alpha
Google News at Macroaxis
few days ago at thelincolnianonline.com         
Kura Oncology Stock Price Down 4.1 percent Heres Why
news
over a week ago at finance.yahoo.com         
What Recent Price Surges Mean for Kura Sushi Investors in 2025
Yahoo News
over a week ago at www.macroaxis.com         
Acquisition by Wilson Troy Edward of 50000 shares of Kura Oncology at 8.2029 subject to Rule 16b-3
Macroaxis News
over two weeks ago at finance.yahoo.com         
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635
Yahoo News
over two weeks ago at news.google.com         
Why is Kura Oncology Inc. stock going up - Buy Signal Expert-Curated Trade Recommendations - khodrob...
Google News at Macroaxis
over two weeks ago at news.google.com         
First Clinical Data Kuras Next-Gen Cancer Drug KO-2806 Shows Promise in Multiple Tumor Types - Stock...
Google News at Macroaxis
over two weeks ago at news.google.com         
Is Kura Oncology Inc. stock poised for growth - 2025 Momentum Check High Accuracy Swing Trade Signal...
Google News at Macroaxis
over two weeks ago at news.google.com         
Kura Oncology Inc. stock chart pattern explained - 2025 Earnings Surprises Reliable Entry Point Trad...
Google News at Macroaxis
over three weeks ago at news.google.com         
Has Kura Oncology Inc. found a price floor - Jobs Report AI Forecast Swing Trade Picks - Newser
Google News at Macroaxis
a minute ago at finance.yahoo.com         
Heres What Key Metrics Tell Us About Vertex Q4 Earnings
Yahoo News
2 days ago at thelincolnianonline.com         
SK Wealth Management LLC Has 444,000 Stock Holdings in Vertex Pharmaceuticals Incorporated VRTX
news
3 days ago at massdevice.com         
Jupiter Endovascular wins FDA clearance for Vertex catheter
news
few days ago at finance.yahoo.com         
NJ Healthy Aging Summit to Promote Wellness, Prevention, and Safer Pain Management for Older Adults
Yahoo News
few days ago at thelincolnianonline.com         
E. Ohman J or Asset Management AB Has 4.68 Million Stock Position in Vertex Pharmaceuticals Incorpor...
news
few days ago at thelincolnianonline.com         
Vertex Pharmaceuticals Incorporated VRTX Shares Sold by Baker Ellis Asset Management LLC
news
over a week ago at thelincolnianonline.com         
1248 Management LLC Has 870,000 Stock Holdings in Vertex Pharmaceuticals Incorporated VRTX
news
over a week ago at finance.yahoo.com         
American Kidney Fund Convenes Kidney Community Members for Sixth Annual Summit on Unknown Causes of ...
Yahoo News
over a week ago at desmoinesregister.com         
University of Iowa doctor wins American Nobel for significant cystic fibrosis research
news
over a week ago at finance.yahoo.com         
Rare Kidney Disease Community Members Join American Kidney Fund and IgA Nephropathy Foundation on Ca...
Yahoo News
a day ago at finance.yahoo.com         
KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY , First an...
Yahoo News
few days ago at news.google.com         
Woodline Partners LP Raises Holdings in KalVista Pharmaceuticals, Inc. KALV - MarketBeat
Google News at Macroaxis
over a week ago at thelincolnianonline.com         
Insider Selling KalVista Pharmaceuticals CEO Sells 115,536.96 in Stock
news
over a week ago at seekingalpha.com         
KalVista Pharmaceuticals GAAP EPS of -1.12 misses by 0.17, revenue of 1.43M misses by 0.66M
seekingalpha News
over a week ago at benzinga.com         
KalVista Pharmas Earnings A Preview
benzinga news
over two weeks ago at simplywall.st         
Is KalVista Pharmaceuticals A Risky Investment?
Simply Wall St News at Macroaxis
over two weeks ago at thelincolnianonline.com         
KalVista Pharmaceuticals, Inc. KALV Shares Sold by Allostery Investments LP
news
over three weeks ago at thelincolnianonline.com         
KalVista Pharmaceuticals Insider Sells 38,893.24 in Stock
news
over three weeks ago at news.google.com         
Disposition of 2336 shares by Audhya Paul K. of Kalvista Pharmaceuticals at 13.42 subject to Rule 16...
Google News at Macroaxis
over three weeks ago at www.macroaxis.com         
Disposition of 2942 shares by Audhya Paul K. of Kalvista Pharmaceuticals at 13.2228 subject to Rule ...
Macroaxis News
a day ago at news.google.com         
Can AnaptysBio Inc reach all time highs this year - Portfolio Return Report AI Optimized Trading Str...
Google News at Macroaxis
few days ago at thelincolnianonline.com         
AnaptysBio Receives Outperform Rating from Wedbush
news
few days ago at news.google.com         
AnaptysBio, Inc. Given Consensus Rating of Moderate Buy by Brokerages - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Trexquant Investment LP Acquires 92,843 Shares of AnaptysBio, Inc. ANAB - MarketBeat
Google News at Macroaxis
over two weeks ago at finance.yahoo.com         
ANAB Establishes the Digital Technology Initiative and AI Task Force
Yahoo News
over two weeks ago at news.google.com         
AnaptysBio Inc. stock momentum explained - Weekly Trade Recap Free High Return Stock Watch Alerts - ...
Google News at Macroaxis
over three weeks ago at news.google.com         
AnaptysBio Inc. Rebounds From Oversold Zone Now What getLinesFromResByArray error size 0 -
Google News at Macroaxis
over three weeks ago at news.google.com         
Chart based analysis of AnaptysBio Inc. trends - July 2025 EndofMonth Accurate EntryExit Alerts - Ne...
Google News at Macroaxis
over three weeks ago at news.google.com         
Historical volatility pattern of AnaptysBio Inc. visualized - July 2025 WrapUp Verified Chart Patter...
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
Wedbush Brokers Raise Earnings Estimates for AnaptysBio
news
2 days ago at prnewswire.com         
Anti-Aging Biotech Surges as 101M Competition Ignites Global Race Against Aging Demographics
prnewswire News
over a week ago at news.google.com         
OMERS ADMINISTRATION Corp Takes 152,000 Position in uniQure N.V. QURE - MarketBeat
Google News at Macroaxis
over two weeks ago at globenewswire.com         
uniQure Announces Initial AMT-191 Phase IIIa Data Showing Sustained Increases in -Gal A Enzyme Activ...
Macroaxis News: globenewswire.com
over two weeks ago at thelincolnianonline.com         
Rafferty Asset Management LLC Invests 875,000 in uniQure N.V. QURE
news
over two weeks ago at news.google.com         
Using economic indicators to assess uniQure N.V. potential - 2025 Top Gainers High Conviction Invest...
Google News at Macroaxis
over three weeks ago at news.google.com         
Building trade automation scripts for uniQure N.V. - July 2025 Reactions Daily Profit Focused Stock ...
Google News at Macroaxis
over three weeks ago at news.google.com         
How to build a dashboard for uniQure N.V. stock - July 2025 Macro Moves High Return Trade Opportunit...
Google News at Macroaxis
over three weeks ago at news.google.com         
uniQure N.V. Facing Inflection Point in Trend Analysis - July 2025 Selloffs High Return Stock Watch ...
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
uniQure Upgraded at Mizuho
news
over a month ago at thelincolnianonline.com         
uniQure Upgraded by Wall Street Zen to Hold Rating
news
over a month ago at thelincolnianonline.com         
Sage Therapeutics, Inc. Receives Consensus Recommendation of Reduce from Analysts
news
over a month ago at thelincolnianonline.com         
Sage Therapeutics Upgraded to Hold at Wall Street Zen
news
over a month ago at finance.yahoo.com         
Disposition of 174000 shares by Barry Greene of Sage Therapeutic at 6.97 subject to Rule 16b-3
Yahoo News
over a month ago at zacks.com         
Sage Therapeutics, Inc. Reports Q2 Loss, Beats Revenue Estimates
zacks News
over a month ago at finance.yahoo.com         
ZURZUVAE Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression
Yahoo News
over a month ago at finance.yahoo.com         
FISPAN Powers 1,000 Businesses in Sage Intacct as Demand for Embedded ERP Banking Services Accelerat...
Yahoo News
over two months ago at www.macroaxis.com         
Acquisition by Iguchi Kimi of 3500 shares of Sage Therapeutic subject to Rule 16b-3
Macroaxis News
over two months ago at gurufocus.com         
SAGE Scotiabank Downgrades Sage Therapeutics with Price Target Adjustment SAGE Stock News
Gurufocus Stories at Macroaxis
over two months ago at thelincolnianonline.com         
Sage Therapeutics Share Price Passes Above Two Hundred Day Moving Average Heres Why
news
over two months ago at globenewswire.com         
HAREHOLDER ALERT Class Action Attorney Juan Monteverde Investigates the Merger of Sage Therapeutics,...
Macroaxis News: globenewswire.com
There is far too much social signal, news, headlines, and media speculation about Eventide Healthcare that are available to investors today. This information is accessible both publicly - through Eventide Healthcare's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Eventide-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Eventide Healthcare news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Eventide Healthcare relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Eventide Healthcare's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Eventide Healthcare alpha.

Other Information on Investing in Eventide Mutual Fund

Eventide Healthcare financial ratios help investors to determine whether Eventide Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eventide with respect to the benefits of owning Eventide Healthcare security.
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity